Tetraphase Pharmaceuticals Inc Quick Ratio (TTPH) starting from the first quarter 2020 to first quarter 2019, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Tetraphase Pharmaceuticals Inc  (NASDAQ: TTPH)

Tetraphase Pharmaceuticals Inc's Quick Ratio

TTPH's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Tetraphase Pharmaceuticals Inc's Cash & cash equivalent grew by 23.1 % in the Q1 2020 sequentially, while Current Liabilities decreased, this led to improvement in Tetraphase Pharmaceuticals Inc's Quick Ratio to 3.21, Quick Ratio remained below Tetraphase Pharmaceuticals Inc average.

Within Major Pharmaceutical Preparations industry 279 other companies have achieved higher Quick Ratio than Tetraphase Pharmaceuticals Inc in first quarter 2020. While Quick Ratio total ranking in the first quarter 2020 has deteriorated compared to the prior quarter from 791 to 976.

Explain Quick Ratio?
How much Cash & cash equivalents TTPH´s has?
What are TTPH´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TTPH Quick Ratio (Mar 31 2020)
Q1		 (Dec 31 2019)
Q4		 (Sep 30 2019)
Q3		 (Jun 30 2019)
Q2		 (Mar 31 2019)
Q1
Y / Y Current Liabilities Change -38.98 % -34.68 % -17.89 % 75.07 % -22.41 %
Y / Y Cash & cash equivalent Change -70.14 % -80.29 % -74.72 % -36.19 % -25.59 %
Quick Ratio MRQ 3.21 2.17 2.07 3.7 6.56
TTPH's Total Ranking # 976 # 791 # 851 # 680 # 410
Seq. Current Liabilities Change -16.64 % -17.32 % -38.43 % 43.8 % -10.76 %
Seq. Cash & cash equivalent Change 23.1 % -13.34 % -65.46 % -18.96 % -18.76 %



Quick Ratio first quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 280
Healthcare Sector # 450
Overall Market # 976


Quick Ratio Statistics
High Average Low
20.91 8.81 1.42
(Sep 30 2015)   (Dec 31 2012)




Financial Statements
Tetraphase Pharmaceuticals Inc's Current Liabilities $ 8 Millions Visit TTPH's Balance sheet
Tetraphase Pharmaceuticals Inc's Cash & cash equivalent $ 26 Millions Visit TTPH's Balance sheet
Source of TTPH's Sales Visit TTPH's Sales by Geography


Cumulative Tetraphase Pharmaceuticals Inc's Quick Ratio

TTPH's Quick Ratio for the trailling 12 Months

TTPH Quick Ratio

 (Mar 31 2020)
12 Months		 (Dec 31 2019)
12 Months		 (Sep 30 2019)
12 Months		 (Jun 30 2019)
12 Months		 (Mar 31 2019)
12 Months
Y / Y Current Liabilities TTM Growth -8.82 % -5.89 % -4.62 % -12.04 % -32.92 %
Y / Y Cash & cash equivalent TTM Growth -64.6 % -52.89 % -37.09 % -31.03 % -24.39 %
Quick Ratio TTM 2.92 3.77 4.9 5.87 7.52
Total Ranking TTM # 4686 # 601 # 4516 # 4334 # 160
Seq. Current Liabilities TTM Growth -9.61 % -8.74 % -4.16 % 15.34 % -6.7 %
Seq. Cash & cash equivalent TTM Growth -30.07 % -29.76 % -19.95 % -9.97 % -6.94 %

Quick ratio ranking by company, industry and sector >> Back to TTPH Financial Strength Comparisons >> Go to Compare TTPH Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in TTPH's Current Liabilities to $8.14 millions, cumulative Quick Ratio to 2.92 below the TTPH average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 487 other companies have achieved higher Quick Ratio than Tetraphase Pharmaceuticals Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2019 from 601 to 4686.

Explain Quick Ratio?
How much Cash & cash equivalents TTPH´s has?
What are TTPH´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 488
Healthcare Sector # 931
Within the Market # 4686


trailing twelve months Quick Ratio Statistics
High Average Low
19 9.9 2.92
(Jun 30 2016)   (Mar 31 2020)




Companies with similar Quick Ratio in the quarter ending Mar 31 2020, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2020 MRQ Cash & cash equivalentMar 31 2020 MRQ Current Liabilities
Gyre Therapeutics Inc   8.82 $ 104.528  Millions$ 11.853  Millions
United Therapeutics Corporation  8.81 $ 1,544.500  Millions$ 175.300  Millions
Kalvista Pharmaceuticals Inc   8.77 $ 67.714  Millions$ 7.720  Millions
Xencor Inc  8.67 $ 571.649  Millions$ 65.917  Millions
Calithera Biosciences Inc   8.58 $ 135.104  Millions$ 15.753  Millions
Global Blood Therapeutics Inc.  8.53 $ 530.820  Millions$ 62.248  Millions
Ironwood Pharmaceuticals inc   8.38 $ 231.143  Millions$ 27.595  Millions
Lite Strategy Inc   8.32 $ 85.360  Millions$ 10.257  Millions
Avenue Therapeutics Inc   8.32 $ 6.574  Millions$ 0.790  Millions
Novabridge Biosciences  8.31 $ 734.147  Millions$ 88.295  Millions
Aimmune Therapeutics Inc   8.31 $ 358.351  Millions$ 43.104  Millions
Gracell Biotechnologies Inc   8.28 $ 118.475  Millions$ 14.308  Millions
Tiziana Life Sciences Ltd  8.25 $ 65.824  Millions$ 7.980  Millions
Geron Corporation  8.23 $ 132.386  Millions$ 16.087  Millions
Inovio Pharmaceuticals Inc   8.17 $ 269.998  Millions$ 33.061  Millions
Kineta Inc   8.13 $ 57.104  Millions$ 7.025  Millions
Scienture Holdings Inc   8.10 $ 7.701  Millions$ 0.951  Millions
Kyntra Bio Inc   8.10 $ 535.429  Millions$ 66.101  Millions
Schrodinger Inc   7.94 $ 288.254  Millions$ 36.315  Millions
Arvinas Inc   7.92 $ 262.834  Millions$ 33.169  Millions
Oragenics Inc   7.74 $ 14.372  Millions$ 1.858  Millions
Myokardia Inc   7.67 $ 350.013  Millions$ 45.660  Millions
Arena Pharmaceuticals Inc   7.63 $ 191.093  Millions$ 25.042  Millions
Decoy Therapeutics Inc   7.61 $ 9.647  Millions$ 1.267  Millions
Agios Pharmaceuticals Inc   7.57 $ 528.621  Millions$ 69.858  Millions
Axsome Therapeutics Inc   7.56 $ 197.313  Millions$ 26.100  Millions
Marinus Pharmaceuticals Inc   7.53 $ 77.786  Millions$ 10.325  Millions
Arcus Biosciences Inc   7.52 $ 157.866  Millions$ 21.004  Millions
Unity Biotechnology Inc   7.50 $ 109.238  Millions$ 14.569  Millions
Beone Medicines Ltd   7.47 $ 3,374.480  Millions$ 451.797  Millions

Date modified: 2026-08-29T17:23:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.